Global Sacral Neuromodulation System Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: G2F46516A601EN
QYResearch

Abstracts

This report focuses on the global Sacral Neuromodulation System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sacral Neuromodulation System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Medtronic, Inc. (US)
• Boston Scientific Corporation (US)
• St. Jude Medical, Inc. (US)
• Synapse Biomedical, Inc. (US)
• Nevro Corporation (US)
• Neurosigma, Inc. (US)
• Neuropace, Inc. (US)
• Neuronetics, Inc. (US)
• Cyberonics, Inc. (US)
• BioControl Medical (Israel)

Market segment by Type, the product can be split into

• Internal Neuromodulation System
• External Neuromodulation System

Market segment by Application, split into

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Sacral Neuromodulation System status, future forecast, growth opportunity, key market and key players.
• To present the Sacral Neuromodulation System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sacral Neuromodulation System are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sacral Neuromodulation System Revenue
1.4 Market Analysis by Type
  1.4.1 Global Sacral Neuromodulation System Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Internal Neuromodulation System
  1.4.3 External Neuromodulation System
1.5 Market by Application
  1.5.1 Global Sacral Neuromodulation System Market Share by Application: 2020 VS 2026
  1.5.2 Spinal Cord Stimulation
  1.5.3 Deep Brain Stimulation
  1.5.4 Sacral Nerve Stimulation
  1.5.5 Vagus Nerve Stimulation
1.6 Coronavirus Disease 2019 (Covid-19): Sacral Neuromodulation System Industry Impact
  1.6.1 How the Covid-19 is Affecting the Sacral Neuromodulation System Industry
    1.6.1.1 Sacral Neuromodulation System Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Sacral Neuromodulation System Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Sacral Neuromodulation System Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Sacral Neuromodulation System Market Perspective (2015-2026)
2.2 Sacral Neuromodulation System Growth Trends by Regions
  2.2.1 Sacral Neuromodulation System Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Sacral Neuromodulation System Historic Market Share by Regions (2015-2020)
  2.2.3 Sacral Neuromodulation System Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Sacral Neuromodulation System Market Growth Strategy
  2.3.6 Primary Interviews with Key Sacral Neuromodulation System Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sacral Neuromodulation System Players by Market Size
  3.1.1 Global Top Sacral Neuromodulation System Players by Revenue (2015-2020)
  3.1.2 Global Sacral Neuromodulation System Revenue Market Share by Players (2015-2020)
  3.1.3 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sacral Neuromodulation System Market Concentration Ratio
  3.2.1 Global Sacral Neuromodulation System Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Sacral Neuromodulation System Revenue in 2019
3.3 Sacral Neuromodulation System Key Players Head office and Area Served
3.4 Key Players Sacral Neuromodulation System Product Solution and Service
3.5 Date of Enter into Sacral Neuromodulation System Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Sacral Neuromodulation System Historic Market Size by Type (2015-2020)
4.2 Global Sacral Neuromodulation System Forecasted Market Size by Type (2021-2026)

5 SACRAL NEUROMODULATION SYSTEM BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Sacral Neuromodulation System Market Size by Application (2015-2020)
5.2 Global Sacral Neuromodulation System Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Sacral Neuromodulation System Market Size (2015-2020)
6.2 Sacral Neuromodulation System Key Players in North America (2019-2020)
6.3 North America Sacral Neuromodulation System Market Size by Type (2015-2020)
6.4 North America Sacral Neuromodulation System Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Sacral Neuromodulation System Market Size (2015-2020)
7.2 Sacral Neuromodulation System Key Players in Europe (2019-2020)
7.3 Europe Sacral Neuromodulation System Market Size by Type (2015-2020)
7.4 Europe Sacral Neuromodulation System Market Size by Application (2015-2020)

8 CHINA

8.1 China Sacral Neuromodulation System Market Size (2015-2020)
8.2 Sacral Neuromodulation System Key Players in China (2019-2020)
8.3 China Sacral Neuromodulation System Market Size by Type (2015-2020)
8.4 China Sacral Neuromodulation System Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Sacral Neuromodulation System Market Size (2015-2020)
9.2 Sacral Neuromodulation System Key Players in Japan (2019-2020)
9.3 Japan Sacral Neuromodulation System Market Size by Type (2015-2020)
9.4 Japan Sacral Neuromodulation System Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Sacral Neuromodulation System Market Size (2015-2020)
10.2 Sacral Neuromodulation System Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sacral Neuromodulation System Market Size by Type (2015-2020)
10.4 Southeast Asia Sacral Neuromodulation System Market Size by Application (2015-2020)

11 INDIA

11.1 India Sacral Neuromodulation System Market Size (2015-2020)
11.2 Sacral Neuromodulation System Key Players in India (2019-2020)
11.3 India Sacral Neuromodulation System Market Size by Type (2015-2020)
11.4 India Sacral Neuromodulation System Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Sacral Neuromodulation System Market Size (2015-2020)
12.2 Sacral Neuromodulation System Key Players in Central & South America (2019-2020)
12.3 Central & South America Sacral Neuromodulation System Market Size by Type (2015-2020)
12.4 Central & South America Sacral Neuromodulation System Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Medtronic, Inc. (US)
  13.1.1 Medtronic, Inc. (US) Company Details
  13.1.2 Medtronic, Inc. (US) Business Overview and Its Total Revenue
  13.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction
  13.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020))
  13.1.5 Medtronic, Inc. (US) Recent Development
13.2 Boston Scientific Corporation (US)
  13.2.1 Boston Scientific Corporation (US) Company Details
  13.2.2 Boston Scientific Corporation (US) Business Overview and Its Total Revenue
  13.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction
  13.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.2.5 Boston Scientific Corporation (US) Recent Development
13.3 St. Jude Medical, Inc. (US)
  13.3.1 St. Jude Medical, Inc. (US) Company Details
  13.3.2 St. Jude Medical, Inc. (US) Business Overview and Its Total Revenue
  13.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction
  13.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.3.5 St. Jude Medical, Inc. (US) Recent Development
13.4 Synapse Biomedical, Inc. (US)
  13.4.1 Synapse Biomedical, Inc. (US) Company Details
  13.4.2 Synapse Biomedical, Inc. (US) Business Overview and Its Total Revenue
  13.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction
  13.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.4.5 Synapse Biomedical, Inc. (US) Recent Development
13.5 Nevro Corporation (US)
  13.5.1 Nevro Corporation (US) Company Details
  13.5.2 Nevro Corporation (US) Business Overview and Its Total Revenue
  13.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction
  13.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.5.5 Nevro Corporation (US) Recent Development
13.6 Neurosigma, Inc. (US)
  13.6.1 Neurosigma, Inc. (US) Company Details
  13.6.2 Neurosigma, Inc. (US) Business Overview and Its Total Revenue
  13.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction
  13.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.6.5 Neurosigma, Inc. (US) Recent Development
13.7 Neuropace, Inc. (US)
  13.7.1 Neuropace, Inc. (US) Company Details
  13.7.2 Neuropace, Inc. (US) Business Overview and Its Total Revenue
  13.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction
  13.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.7.5 Neuropace, Inc. (US) Recent Development
13.8 Neuronetics, Inc. (US)
  13.8.1 Neuronetics, Inc. (US) Company Details
  13.8.2 Neuronetics, Inc. (US) Business Overview and Its Total Revenue
  13.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction
  13.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.8.5 Neuronetics, Inc. (US) Recent Development
13.9 Cyberonics, Inc. (US)
  13.9.1 Cyberonics, Inc. (US) Company Details
  13.9.2 Cyberonics, Inc. (US) Business Overview and Its Total Revenue
  13.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction
  13.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.9.5 Cyberonics, Inc. (US) Recent Development
13.10 BioControl Medical (Israel)
  13.10.1 BioControl Medical (Israel) Company Details
  13.10.2 BioControl Medical (Israel) Business Overview and Its Total Revenue
  13.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction
  13.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2015-2020)
  13.10.5 BioControl Medical (Israel) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Sacral Neuromodulation System Key Market Segments
Table 2. Key Players Covered: Ranking by Sacral Neuromodulation System Revenue
Table 3. Ranking of Global Top Sacral Neuromodulation System Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sacral Neuromodulation System Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Internal Neuromodulation System
Table 6. Key Players of External Neuromodulation System
Table 7. COVID-19 Impact Global Market: (Four Sacral Neuromodulation System Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Sacral Neuromodulation System Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Sacral Neuromodulation System Players to Combat Covid-19 Impact
Table 12. Global Sacral Neuromodulation System Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Sacral Neuromodulation System Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Sacral Neuromodulation System Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Sacral Neuromodulation System Market Share by Regions (2015-2020)
Table 16. Global Sacral Neuromodulation System Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Sacral Neuromodulation System Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Sacral Neuromodulation System Market Growth Strategy
Table 22. Main Points Interviewed from Key Sacral Neuromodulation System Players
Table 23. Global Sacral Neuromodulation System Revenue by Players (2015-2020) (Million US$)
Table 24. Global Sacral Neuromodulation System Market Share by Players (2015-2020)
Table 25. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2019)
Table 26. Global Sacral Neuromodulation System by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Sacral Neuromodulation System Product Solution and Service
Table 29. Date of Enter into Sacral Neuromodulation System Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 32. Global Sacral Neuromodulation System Market Size Share by Type (2015-2020)
Table 33. Global Sacral Neuromodulation System Revenue Market Share by Type (2021-2026)
Table 34. Global Sacral Neuromodulation System Market Size Share by Application (2015-2020)
Table 35. Global Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 36. Global Sacral Neuromodulation System Market Size Share by Application (2021-2026)
Table 37. North America Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 39. North America Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 40. North America Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 41. North America Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 42. North America Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 43. Europe Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 45. Europe Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 47. Europe Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 49. China Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 50. China Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 51. China Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 52. China Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 53. China Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 54. China Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 55. Japan Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 57. Japan Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 59. Japan Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 63. Southeast Asia Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 65. Southeast Asia Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 67. India Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 68. India Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 69. India Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 70. India Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 71. India Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 72. India Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 75. Central & South America Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 77. Central & South America Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 79. Medtronic, Inc. (US) Company Details
Table 80. Medtronic, Inc. (US) Business Overview
Table 81. Medtronic, Inc. (US) Product
Table 82. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 83. Medtronic, Inc. (US) Recent Development
Table 84. Boston Scientific Corporation (US) Company Details
Table 85. Boston Scientific Corporation (US) Business Overview
Table 86. Boston Scientific Corporation (US) Product
Table 87. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 88. Boston Scientific Corporation (US) Recent Development
Table 89. St. Jude Medical, Inc. (US) Company Details
Table 90. St. Jude Medical, Inc. (US) Business Overview
Table 91. St. Jude Medical, Inc. (US) Product
Table 92. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 93. St. Jude Medical, Inc. (US) Recent Development
Table 94. Synapse Biomedical, Inc. (US) Company Details
Table 95. Synapse Biomedical, Inc. (US) Business Overview
Table 96. Synapse Biomedical, Inc. (US) Product
Table 97. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 98. Synapse Biomedical, Inc. (US) Recent Development
Table 99. Nevro Corporation (US) Company Details
Table 100. Nevro Corporation (US) Business Overview
Table 101. Nevro Corporation (US) Product
Table 102. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 103. Nevro Corporation (US) Recent Development
Table 104. Neurosigma, Inc. (US) Company Details
Table 105. Neurosigma, Inc. (US) Business Overview
Table 106. Neurosigma, Inc. (US) Product
Table 107. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 108. Neurosigma, Inc. (US) Recent Development
Table 109. Neuropace, Inc. (US) Company Details
Table 110. Neuropace, Inc. (US) Business Overview
Table 111. Neuropace, Inc. (US) Product
Table 112. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 113. Neuropace, Inc. (US) Recent Development
Table 114. Neuronetics, Inc. (US) Business Overview
Table 115. Neuronetics, Inc. (US) Product
Table 116. Neuronetics, Inc. (US) Company Details
Table 117. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 118. Neuronetics, Inc. (US) Recent Development
Table 119. Cyberonics, Inc. (US) Company Details
Table 120. Cyberonics, Inc. (US) Business Overview
Table 121. Cyberonics, Inc. (US) Product
Table 122. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 123. Cyberonics, Inc. (US) Recent Development
Table 124. BioControl Medical (Israel) Company Details
Table 125. BioControl Medical (Israel) Business Overview
Table 126. BioControl Medical (Israel) Product
Table 127. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 128. BioControl Medical (Israel) Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Sacral Neuromodulation System Market Share by Type: 2020 VS 2026
Figure 2. Internal Neuromodulation System Features
Figure 3. External Neuromodulation System Features
Figure 4. Global Sacral Neuromodulation System Market Share by Application: 2020 VS 2026
Figure 5. Spinal Cord Stimulation Case Studies
Figure 6. Deep Brain Stimulation Case Studies
Figure 7. Sacral Nerve Stimulation Case Studies
Figure 8. Vagus Nerve Stimulation Case Studies
Figure 9. Sacral Neuromodulation System Report Years Considered
Figure 10. Global Sacral Neuromodulation System Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sacral Neuromodulation System Market Share by Regions: 2020 VS 2026
Figure 12. Global Sacral Neuromodulation System Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sacral Neuromodulation System Market Share by Players in 2019
Figure 15. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2019
Figure 17. North America Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Medtronic, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 26. Boston Scientific Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 28. St. Jude Medical, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 30. Synapse Biomedical, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 32. Nevro Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 34. Neurosigma, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 36. Neuropace, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 38. Neuronetics, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 40. Cyberonics, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 42. BioControl Medical (Israel) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed